Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 219

1.

Nonalcoholic Fatty Liver Disease and Risk of Incident Cardiovascular Disease: A Meta-Analysis of Observational Studies.

Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C.

J Hepatol. 2016 May 17. pii: S0168-8278(16)30199-4. doi: 10.1016/j.jhep.2016.05.013. [Epub ahead of print]

PMID:
27212244
2.

Body mass index and mortality: understanding the patterns and paradoxes.

Wild SH, Byrne CD.

BMJ. 2016 May 4;353:i2433. doi: 10.1136/bmj.i2433. No abstract available.

PMID:
27146663
3.

Risk of type 2 diabetes in patients with non-alcoholic fatty liver disease: Causal association or epiphenomenon?

Targher G, Marchesini G, Byrne CD.

Diabetes Metab. 2016 Apr 30. pii: S1262-3636(16)30394-9. doi: 10.1016/j.diabet.2016.04.002. [Epub ahead of print] Review.

PMID:
27142870
4.

Insulin-induced hypoglycaemia and the detection of myocardial injury using an ultrasensitive troponin assay.

Quah J, Carlton E, Rana O, Byrne CD, Senior R, Anstey C, Greaves K.

Int J Cardiol. 2016 Jul 15;215:446-8. doi: 10.1016/j.ijcard.2016.03.238. Epub 2016 Apr 10. No abstract available.

PMID:
27131269
5.
6.

MNK1 and MNK2 mediate adverse effects of high-fat feeding in distinct ways.

Moore CE, Pickford J, Cagampang FR, Stead RL, Tian S, Zhao X, Tang X, Byrne CD, Proud CG.

Sci Rep. 2016 Apr 18;6:23476. doi: 10.1038/srep23476.

7.

EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: is universal screening appropriate?

Byrne CD, Targher G.

Diabetologia. 2016 Jun;59(6):1141-4. doi: 10.1007/s00125-016-3910-y. Epub 2016 Apr 7.

PMID:
27053232
8.

Altered cellular redox status, sirtuin abundance and clock gene expression in a mouse model of developmentally primed NASH.

Bruce KD, Szczepankiewicz D, Sihota KK, Ravindraanandan M, Thomas H, Lillycrop KA, Burdge GC, Hanson MA, Byrne CD, Cagampang FR.

Biochim Biophys Acta. 2016 Jul;1861(7):584-93. doi: 10.1016/j.bbalip.2016.03.026. Epub 2016 Apr 23.

9.

Global epidemiology of non-alcoholic fatty liver disease. Meta-analytic assessment of prevalence, incidence and outcomes.

Lonardo A, Byrne CD, Caldwell SH, Cortez-Pinto H, Targher G.

Hepatology. 2016 Mar 31. doi: 10.1002/hep.28584. [Epub ahead of print] No abstract available.

PMID:
27038241
10.

Fatty Liver, Insulin Resistance, and Obesity: Relationships With Increase in Coronary Artery Calcium Over Time.

Sung KC, Ryu S, Lee JY, Lee SH, Cheong ES, Wild SH, Byrne CD.

Clin Cardiol. 2016 Mar 21. doi: 10.1002/clc.22529. [Epub ahead of print]

11.

Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic Syndrome.

Wainwright P, Byrne CD.

Int J Mol Sci. 2016 Mar 11;17(3). pii: E367. doi: 10.3390/ijms17030367. Review.

12.

Change in fatty liver status and 5-year risk of incident metabolic syndrome: a retrospective cohort study.

Han EN, Cheong ES, Lee JI, Kim MC, Byrne CD, Sung KC.

Clin Hypertens. 2015 Nov 17;21:22. doi: 10.1186/s40885-015-0032-7. eCollection 2015.

13.

Nonalcoholic Fatty Liver Disease Is Associated With Higher 1-year All-Cause Rehospitalization Rates in Patients Admitted for Acute Heart Failure.

Valbusa F, Bonapace S, Grillo C, Scala L, Chiampan A, Rossi A, Zoppini G, Lonardo A, Arcaro G, Byrne CD, Targher G.

Medicine (Baltimore). 2016 Feb;95(7):e2760. doi: 10.1097/MD.0000000000002760.

14.

Type 2 diabetes and risk of hospital admission or death for chronic liver diseases.

Wild SH, Morling JR, McAllister DA, Kerssens J, Fischbacher C, Parkes J, Roderick PJ, Sattar N, Byrne CD; Scottish and Southampton Diabetes and Liver Disease Group; Scottish Diabetes Research Network Epidemiology Group.

J Hepatol. 2016 Jun;64(6):1358-64. doi: 10.1016/j.jhep.2016.01.014. Epub 2016 Jan 23.

PMID:
26812073
15.

Improvement in non-alcoholic fatty liver disease severity is associated with a reduction in carotid intima-media thickness progression.

Bhatia L, Scorletti E, Curzen N, Clough GF, Calder PC, Byrne CD.

Atherosclerosis. 2016 Mar;246:13-20. doi: 10.1016/j.atherosclerosis.2015.12.028. Epub 2015 Dec 24.

PMID:
26748347
16.

Time to Replace Assessment of Liver Histology With MR-Based Imaging Tests to Assess Efficacy of Interventions for Nonalcoholic Fatty Liver Disease.

Byrne CD, Targher G.

Gastroenterology. 2016 Jan;150(1):7-10. doi: 10.1053/j.gastro.2015.11.016. Epub 2015 Nov 18. No abstract available.

PMID:
26602219
17.

Mulberry extract to modULate Blood glucosE Responses in noRmoglYcaemic adults (MULBERRY): study protocol for a randomised controlled trial.

Lown M, Fuller R, Lightowler H, Fraser A, Gallagher A, Stuart B, Byrne CD, Lewith G.

Trials. 2015 Oct 28;16:486. doi: 10.1186/s13063-015-0997-2.

18.

NAFLD, cardiovascular outcomes and mortality in patients undergoing coronary angiogram.

Targher G, Byrne CD.

Hepatology. 2015 Oct 21. doi: 10.1002/hep.28306. [Epub ahead of print] No abstract available.

PMID:
26486720
19.

Omega-3 fatty acids: Mechanisms of benefit and therapeutic effects in pediatric and adult NAFLD.

Nobili V, Alisi A, Musso G, Scorletti E, Calder PC, Byrne CD.

Crit Rev Clin Lab Sci. 2016 Apr;53(2):106-20. doi: 10.3109/10408363.2015.1092106. Epub 2015 Oct 14.

PMID:
26463349
20.

Views of People With High and Low Levels of Health Literacy About a Digital Intervention to Promote Physical Activity for Diabetes: A Qualitative Study in Five Countries.

Rowsell A, Muller I, Murray E, Little P, Byrne CD, Ganahl K, Müller G, Gibney S, Lyles CR, Lucas A, Nutbeam D, Yardley L.

J Med Internet Res. 2015 Oct 12;17(10):e230. doi: 10.2196/jmir.4999.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk